BAMS

Bellevue Asset Management (Switzerland) Portfolio holdings

AUM $656M
This Quarter Return
+10.91%
1 Year Return
+11.48%
3 Year Return
5 Year Return
10 Year Return
AUM
$656M
AUM Growth
+$656M
Cap. Flow
-$2.4M
Cap. Flow %
-0.37%
Top 10 Hldgs %
31%
Holding
140
New
7
Increased
41
Reduced
25
Closed
13

Sector Composition

1 Healthcare 93.1%
2 Financials 1.62%
3 Industrials 0.28%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
AST
126
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$7K ﹤0.01%
1,875
BTX.WS
127
DELISTED
BioTime Inc Warrants (Expiring October 1, 2018)
BTX.WS
$3K ﹤0.01%
+2,294
New +$3K
INVA icon
128
Innoviva
INVA
$1.29B
-35,000
Closed -$251K
LCTX icon
129
Lineage Cell Therapeutics
LCTX
$267M
-2,294
Closed -$2K
LRMR icon
130
Larimar Therapeutics
LRMR
$310M
-100,000
Closed -$3.2M
PEN icon
131
Penumbra
PEN
$10.6B
-10,000
Closed -$401K
RDY icon
132
Dr. Reddy's Laboratories
RDY
$11.8B
-130,000
Closed -$8.31M
XRAY icon
133
Dentsply Sirona
XRAY
$2.85B
-58,400
Closed -$2.95M
LFWD icon
134
ReWalk Robotics
LFWD
$9.97M
-30,000
Closed -$229K
AKRX
135
DELISTED
Akorn, Inc.
AKRX
-112,470
Closed -$3.21M
AGN
136
DELISTED
Allergan plc
AGN
-50,150
Closed -$13.6M
UBIO
137
DELISTED
Proshares UltraPro NASDAQ Biotechnology
UBIO
-35,000
Closed -$2.04M
ELGX
138
DELISTED
Endologix Inc
ELGX
-50,000
Closed -$613K
KANG
139
DELISTED
iKang Healthcare Group, Inc.
KANG
-75,000
Closed -$1.11M
DYAX
140
DELISTED
DYAX CORPORATION
DYAX
-15,000
Closed -$286K